Dominion Diagnostics Executive and Leadership Team

Robert Garvey, the Chief Executive Officer at Dominion Diagnostics, directs the overarching strategic vision for clinical laboratory operations. This leadership role involves aligning diagnostic testing services with the evolving needs of behavioral health and primary care providers. Robert Garvey architects long-term growth initiatives while ensuring the laboratory maintains rigorous standards for medication management support. By fostering partnerships with hospital systems, the Chief Executive Officer expands the reach of drug monitoring solutions across the United States. The Chief Executive Officer monitors market trends to identify opportunities for service innovation, ensuring the organization remains a leader in clinical information delivery. Through consistent engagement with the Board, the Chief Executive Officer secures the resources necessary for technological advancement. Ultimately, the Chief Executive Officer drives the company mission to improve patient outcomes through accurate, timely, and actionable diagnostic data, maintaining operational excellence across all regional service lines.

Mark Peters, the Chief Financial Officer at Dominion Diagnostics, manages the fiscal health and capital allocation strategies for the clinical laboratory. This role involves overseeing financial reporting, budgeting, and long-term investment planning to support the expansion of diagnostic testing services. Mark Peters directs the financial planning processes that enable the company to scale operations within the competitive healthcare diagnostics market. By analyzing revenue streams from medication management and substance monitoring, the Chief Financial Officer ensures the organization maintains a robust balance sheet. The Chief Financial Officer collaborates with other executive leaders to optimize resource distribution, directly impacting the efficiency of laboratory workflows. Through rigorous financial oversight, the Chief Financial Officer mitigates fiscal risks while identifying new avenues for sustainable growth. This leadership position requires constant vigilance over economic shifts in the healthcare sector, ensuring the company remains financially agile while delivering critical support to primary care and psychiatry providers.

Dave Senerchia, the Chief Financial Officer & Executive VP, Business Development at Dominion Diagnostics, drives the company expansion strategy through financial planning and market growth initiatives. This role involves identifying new opportunities for diagnostic testing services within primary care and psychiatry sectors. Dave Senerchia architects business development plans that increase the market footprint of the laboratory, ensuring the organization reaches more healthcare providers. By managing the financial aspects of these growth projects, the Chief Financial Officer & Executive VP, Business Development ensures that expansion efforts remain profitable and sustainable. The Chief Financial Officer & Executive VP, Business Development collaborates with the executive team to integrate new service lines into the existing clinical support framework. Through strategic outreach and financial modeling, the Chief Financial Officer & Executive VP, Business Development secures the company position as a preferred partner for medication management. This leadership role directly impacts the long-term revenue trajectory by aligning business development goals with the core mission of providing superior diagnostic testing.

Mark McSally, the Chief Operating Officer & General Counsel at Dominion Diagnostics, manages the intersection of operational efficiency and legal compliance within the clinical laboratory environment. This dual-function role involves streamlining laboratory testing workflows while ensuring adherence to complex healthcare regulations. Mark McSally directs the internal processes that support medication management services for hospital systems and behavioral health facilities. By overseeing the legal framework governing diagnostic testing, the Chief Operating Officer & General Counsel protects the organization against regulatory risks. The Chief Operating Officer & General Counsel coordinates with clinical teams to enhance service delivery speed and accuracy, directly impacting patient care quality. This leadership role requires balancing operational scalability with strict legal standards, ensuring the company maintains its reputation for reliability. Through meticulous management of both legal affairs and daily operations, the Chief Operating Officer & General Counsel secures the foundation for the company to provide consistent, high-quality diagnostic support across diverse healthcare settings.